Jude Onyia
Chief Scientific Officer · NEUROCRINE BIOSCIENCES INC
- 2024
- Sep 15, 2026
- 15
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jude Onyia files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Charles Gorman - $37.82M in NBIX purchases and sales in the last 12 months
- Julie Cooke - $5.77M in NBIX purchases and sales in the last 12 months
- Kyle Gano - $4.87M in NBIX purchases and sales in the last 12 months
- Stephen A. Sherwin - $4.13M in NBIX purchases and sales in the last 12 months
- Ingrid Delaet - $3.75M in NBIX purchases and sales in the last 12 months
- Darin Lippoldt - $3.50M in NBIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jude Onyia?
Jude Onyia is a corporate insider, tracked as Chief Scientific Officer of NEUROCRINE BIOSCIENCES INC (NBIX). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jude Onyia submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jude Onyia been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($14.22M) across all tracked filings.
